Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
227,895,837
-
Number of holders
-
106
-
Total 13F shares, excl. options
-
28,932,069
-
Shares change
-
-5,034,889
-
Total reported value, excl. options
-
$21,120,871
-
Value change
-
-$3,760,598
-
Put/Call ratio
-
22%
-
Number of buys
-
43
-
Number of sells
-
-59
-
Price
-
$0.7300
Significant Holders of Vaxart, Inc. - Common Stock, $0.0001 par value per share (VXRT) as of Q2 2023
135 filings reported holding VXRT - Vaxart, Inc. - Common Stock, $0.0001 par value per share as of Q2 2023.
Vaxart, Inc. - Common Stock, $0.0001 par value per share (VXRT) has 106 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28,932,069 shares
of 227,895,837 outstanding shares and own 13% of the company stock.
Largest 10 shareholders include CANTOR FITZGERALD, L. P. (7,086,341 shares), VANGUARD GROUP INC (6,894,401 shares), MILLENNIUM MANAGEMENT LLC (2,143,638 shares), BlackRock Inc. (1,928,709 shares), GEODE CAPITAL MANAGEMENT, LLC (1,568,909 shares), RENAISSANCE TECHNOLOGIES LLC (792,005 shares), CITADEL ADVISORS LLC (749,684 shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (739,643 shares), STATE STREET CORP (526,745 shares), and Rokos Capital Management LLP (500,000 shares).
This table shows the top 106 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.